Social Sentiment Ticker Powered by AI
Social Sentiment Ticker Powered by AI
Download App
Master the Markets with TradeZing PLUS’s AI Powered Tools
Learn More
Host your events on tradezing app
COMMUNITY AUDIO ROOMS
No available audio rooms
Upcoming Events
TradeZing
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
8 Day3 Hr22 Min16 Sec
YouTube
Get the TradeZing Newsletter
Supercharge
Your Money Making Potential
Watch your wealth rise with the power of AI research tools only with TradeZing PLUS!
Subscribe Now
EXCLUSIVE
Trade the Day
With Larry Benedict and Eric Shamilov
Trade together with legendary hedge fund manager Larry Benedict every morning before the bell
Everyday at 8:45 AM EST
What is Trade the Day?
Get ahead of the market curve each trading day with Larry Benedict, a distinguished Barron’s Top 100 hedge fund manager and the founder of the Opportunistic Trader ETF (WZRD). With his analyst, Eric Shamilov, Larry provides live, pre-market trading insights and strategic analysis, equipping you with the knowledge to make smart trading decisions.
Not a TradeZing PRO Member?
Subscribe now for exclusive advantages and benefits!
Latest Feed
May 16, 2024
36 mins ago
Critical Insights From Praxis Precision Medicine Analyst Ratings: What You Need To Know
Ratings for Praxis Precision Medicine (NASDAQ:PRAX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 6 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 1 0 0 0 2M Ago 2 0 0 0 0 3M Ago 1 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Praxis Precision Medicine, presenting an average target of $116.43, a high estimate of $150.00, and a low estimate of $105.00. This current average has increased by 3.49% from the previous average price target of $112.50. Decoding Analyst Ratings: A Detailed Look A comprehensive examination of how financial experts perceive Praxis Precision Medicine is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Joon Lee Truist Securities Maintains Buy $150.00 $150.00 Douglas Tsao HC Wainwright & Co. Maintains Buy $105.00 – Joel Beatty Baird Announces Outperform $117.00 – Douglas Tsao HC Wainwright & Co. Maintains Buy $105.00 – Kambiz Yazdi Jefferies Raises Buy $128.00 $75.00 Douglas Tsao HC Wainwright & Co. Maintains Buy $105.00 – Douglas Tsao HC Wainwright & Co. Maintains Buy $105.00 – Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ their stance, …Full story available on Benzinga.com
181717
News
May 16, 2024
36 mins ago
The Analyst Landscape: 7 Takes On Coupang
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Coupang (NYSE:CPNG) in the last three months. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 2 1 0 0 Last 30D 1 0 0 0 0 1M Ago 1 1 1 0 0 2M Ago 1 0 0 0 0 3M Ago 1 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Coupang, presenting an average target of $25.86, a high estimate of $32.00, and a low estimate of $21.00. This current average has increased by 19.89% from the previous average price target of $21.57. Breaking Down Analyst Ratings: A Detailed Examination The analysis of recent analyst actions sheds light on the perception of Coupang by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jennifer Han UBS Raises Buy $26.00 $18.50 Jiong Shao Barclays Raises Overweight $32.00 $25.00 John Yu Citigroup Raises Buy $28.00 $26.00 James Lee Mizuho Raises Neutral $23.00 $20.00 John Yu Citigroup Raises Buy $26.00 $19.00 John Shao Barclays Raises Overweight $25.00 $24.00 Peter Milliken Deutsche Bank Raises Buy $21.00 $18.50 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ …Full story available on Benzinga.com
181718
News
May 16, 2024
36 mins ago
Expert Ratings For Caribou Biosciences
Ratings for Caribou Biosciences (NASDAQ:CRBU) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 0 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Caribou Biosciences, presenting an average target of $21.5, a high estimate of $24.00, and a low estimate of $19.00. A decline of 6.52% from the prior average price target is evident in the current average. Exploring Analyst Ratings: An In-Depth Overview A comprehensive examination of how financial experts perceive Caribou Biosciences is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Asthika Goonewardene Truist Securities Maintains Buy $19.00 – Robert Burns HC Wainwright & Co. Maintains Buy $24.00 – Robert Burns HC Wainwright & Co. Raises Buy $24.00 $23.00 Luca Issi RBC Capital Maintains Outperform $19.00 – Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they ‘Maintain’, ‘Raise’, or ‘Lower’ their stance, it signifies their response to recent developments …Full story available on Benzinga.com
181719
News
Copied
Related Events
No related events associated to this feed.
Latest Feed
May 16, 2024
36 mins ago
Critical Insights From Praxis Precision Medicine Analyst Ratings: What You Need To Know
Ratings for Praxis Precision Medicine (NASDAQ:PRAX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 6 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 1 0 0 0 2M Ago 2 0 0 0 0 3M Ago 1 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Praxis Precision Medicine, presenting an average target of $116.43, a high estimate of $150.00, and a low estimate of $105.00. This current average has increased by 3.49% from the previous average price target of $112.50. Decoding Analyst Ratings: A Detailed Look A comprehensive examination of how financial experts perceive Praxis Precision Medicine is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Joon Lee Truist Securities Maintains Buy $150.00 $150.00 Douglas Tsao HC Wainwright & Co. Maintains Buy $105.00 – Joel Beatty Baird Announces Outperform $117.00 – Douglas Tsao HC Wainwright & Co. Maintains Buy $105.00 – Kambiz Yazdi Jefferies Raises Buy $128.00 $75.00 Douglas Tsao HC Wainwright & Co. Maintains Buy $105.00 – Douglas Tsao HC Wainwright & Co. Maintains Buy $105.00 – Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ their stance, …Full story available on Benzinga.com
PRAX
181717
News
May 16, 2024
36 mins ago
The Analyst Landscape: 7 Takes On Coupang
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Coupang (NYSE:CPNG) in the last three months. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 2 1 0 0 Last 30D 1 0 0 0 0 1M Ago 1 1 1 0 0 2M Ago 1 0 0 0 0 3M Ago 1 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Coupang, presenting an average target of $25.86, a high estimate of $32.00, and a low estimate of $21.00. This current average has increased by 19.89% from the previous average price target of $21.57. Breaking Down Analyst Ratings: A Detailed Examination The analysis of recent analyst actions sheds light on the perception of Coupang by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jennifer Han UBS Raises Buy $26.00 $18.50 Jiong Shao Barclays Raises Overweight $32.00 $25.00 John Yu Citigroup Raises Buy $28.00 $26.00 James Lee Mizuho Raises Neutral $23.00 $20.00 John Yu Citigroup Raises Buy $26.00 $19.00 John Shao Barclays Raises Overweight $25.00 $24.00 Peter Milliken Deutsche Bank Raises Buy $21.00 $18.50 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ …Full story available on Benzinga.com
CPNG
181718
News
May 16, 2024
36 mins ago
Expert Ratings For Caribou Biosciences
Ratings for Caribou Biosciences (NASDAQ:CRBU) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 0 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Caribou Biosciences, presenting an average target of $21.5, a high estimate of $24.00, and a low estimate of $19.00. A decline of 6.52% from the prior average price target is evident in the current average. Exploring Analyst Ratings: An In-Depth Overview A comprehensive examination of how financial experts perceive Caribou Biosciences is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Asthika Goonewardene Truist Securities Maintains Buy $19.00 – Robert Burns HC Wainwright & Co. Maintains Buy $24.00 – Robert Burns HC Wainwright & Co. Raises Buy $24.00 $23.00 Luca Issi RBC Capital Maintains Outperform $19.00 – Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they ‘Maintain’, ‘Raise’, or ‘Lower’ their stance, it signifies their response to recent developments …Full story available on Benzinga.com
CRBU
181719
News
Connect with your community
Introducing Audio Rooms: Engage in real-time discussions on community or news topics with fellow users. Each article or post can instantly create its exclusive audio room, facilitating conversations about subjects directly tied to the article or community post.
Audio Room Title:
Morning Minute: Monday, April 29
Someone already created an audio of this feed.
Join the room
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
0 Comments